Passive immunization with RSV-specific antibody can protect infants against severe lower respiratory tract infection (LRTI). This suggests that vaccine-induced antibody could benefit infants and therefore supports maternal vaccination as a potential strategy for protecting young infants. The duration of ...
如果审批顺利，这将是首批针对RSV的疫苗。今天小备就基于综述《Respiratory syncytial virus prevention within reach: the vaccine and monoclonal antibody landscape》带大家认识这个疾病以及回顾当下的RSV疫苗和单细胞抗体，展望前景。一、呼吸道合胞病毒（RSV）是什么？RSV是一种正肺病毒，属于肺炎病毒科。它是婴儿死亡...
All infants younger than 8 months born just before or during their first respiratory syncytial virus (RSV) season should receive a dose of a newly approved monoclonal antibody known as nirsevimab-alip to protect against the virus, the US Centers for Disease Control and Prevention (CDC) ...
上月,Moderna公布了先前针对60岁以上人群的呼吸道合胞病毒(RSV)疫苗试验的可观结果。先前辉瑞也宣布了类似的三期结果,同时正在申请批准针对孕妇的疫苗。如果审批顺利,这将是首批针对RSV的疫苗。今天小备就基于综述《Respiratory syncytial virus prevention within reach: the vaccine and monoclonal antibody landscape》带...
如果审批顺利,这将是首批针对RSV的疫苗。今天小备就基于综述《Respiratory syncytial virus prevention within reach: the vaccine and monoclonal antibody landscape》带大家认识这个疾病以及回顾当下的RSV疫苗和单细胞抗体,展望前景。 一、呼吸道合胞病毒(RSV)是什么? RSV是一种正肺病毒,属于肺炎病毒科。它是婴儿死亡...
先前辉瑞也宣布了类似的三期结果,同时正在申请批准针对孕妇的疫苗。如果审批顺利,这将是首批针对RSV的疫苗。今天小备就基于综述《Respiratory syncytial virus prevention within reach: the vaccine and monoclonal antibody landscape》带大家认识这个疾病以及回顾当下的RSV疫苗和单细胞抗体,展望前景。
In the meantime, infants will have access to anothernewly approved toolcalled nirsevimab -- a monoclonal antibody shot that is recommended for all infants less than 8 months old. "We're hopeful that these two [products] will work together so that we can provide the most protection to ...
上月,Moderna公布了先前针对60岁以上人群的呼吸道合胞病毒(RSV)疫苗试验的可观结果。先前辉瑞也宣布了类似的三期结果,同时正在申请批准针对孕妇的疫苗。如果审批顺利,这将是首批针对RSV的疫苗。今天小备就基于综述《Respiratory syncytial virus prevention within reach: the vaccine and monoclonal antibody landscape》带...
上月,Moderna公布了先前针对60岁以上人群的呼吸道合胞病毒(RSV)疫苗试验的可观结果。先前辉瑞也宣布了类似的三期结果,同时正在申请批准针对孕妇的疫苗。如果审批顺利,这将是首批针对RSV的疫苗。今天小备就基于综述《Respiratory syncytial virus prevention within reach: the vaccine and monoclonal antibody landscape》带...
2. Natalie I Mazur, et al. Respiratory syncytial virus prevention within reach: the vaccine and monoclonal antibody landscape[J]. Lancet Infect Dis. 2023 Jan;23(1):e2-e21. 3. Alaa Ahmad, et al. EDP-938, a Respira...